Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir (pronunciation: gleh-ka-PREH-vir/pee-BREN-tas-vir) is a fixed-dose combination medication used for the treatment of hepatitis C. It is a combination of two antiviral drugs, glecaprevir and pibrentasvir, which work together to inhibit the growth of the hepatitis C virus.
Etymology
The names "glecaprevir" and "pibrentasvir" are derived from the names of the chemical compounds that make up each drug. The "-previr" suffix in both names is common in antiviral drugs and indicates their function as virus inhibitors.
Usage
Glecaprevir/pibrentasvir is used to treat all six genotypes of hepatitis C in adults without cirrhosis or with compensated cirrhosis. It is also used in combination with ribavirin in adults with decompensated cirrhosis.
Related Terms
- Hepatitis C: A viral infection that causes liver inflammation and damage.
- Antiviral drug: A type of medication used specifically for treating viral infections.
- Cirrhosis: Late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions.
- Ribavirin: An antiviral medication used to treat hepatitis C and other viral infections.
Side Effects
Common side effects of glecaprevir/pibrentasvir include headache, fatigue, and nausea. Serious side effects may include reactivation of hepatitis B in those who have previously been infected.
See Also
External links
- Medical encyclopedia article on Glecaprevir/pibrentasvir
- Wikipedia's article - Glecaprevir/pibrentasvir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski